Apr 12 |
Owning 39% shares,institutional owners seem interested in Opthea Limited (ASX:OPT),
|
Apr 4 |
Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conference
|
Apr 3 |
Opthea Appoints Sujal Shah to the Board of Directors
|
Mar 24 |
11 Best ASX Stocks To Buy Now
|
Mar 19 |
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024
|
Mar 5 |
Opthea to Participate in the Leerink Partners Global Biopharma Conference
|
Feb 29 |
Opthea reports H1 results
|
Feb 28 |
Opthea Reports Half-Year Financial Results and Business Updates
|
Feb 19 |
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor
|
Feb 1 |
Opthea Strengthens Team with Key Clinical and Regulatory Hires
|